C41H47N5O2S2
Neat
705.98
Room Temperature
2138169-93-2; Brexpiprazole Impurity 73; 2, 7-bis({4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy})quinoline; 2, 7-bis[4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy]quinoline; 2, 7-Bis(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinoline; S1C2=C(C=C1)C(=CC=C2)N1CCN(CC1)CCCCOC1=NC2=CC(=CC=C2C=C1)OCCCCN1CCN(CC1)C1=CC=CC=2SC=CC=21; 2, 7-Bis[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-quinoline; SCHEMBL19549054; SCHEMBL29433200; EN300-380976; 2, 7-Bis[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-quinoline; Quinoline, 2, 7-bis[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]- (ACI); 2, 7-Bis[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]quinoline (ACI); 2 and 7-Bis([4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy])quinoline
2 and 7-bis[4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy]quinoline
InChI=1S/C41H47N5O2S2/c1(17-43-19-23-45(24-20-43)37-7-5-9-39-34(37)15-29-49-39)3-27-47-33-13-11-32-12-14-41(42-36(32)31-33)48-28-4-2-18-44-21-25-46(26-22-44)38-8-6-10-40-35(38)16-30-50-40/h5-16,29-31H,1-4,17-28H2